Search results

Page results

• Loss of smell a ‘highly specific’ indicator of Covid-19, finds UCLH and UCL research

  Acute loss of sense of smell should be considered globally as a criterion for self-isolation, testing, and contact tracing for Covid-19 infection according to researchers at UCLH and UCL.

• Faster diagnosis pathway for gynaecology

  This page is for patients who have been referred by their GP to a gynaecology specialist because their symptoms need further tests.

• UCLH researchers find way to reduce side effects of treatment for adrenal disorder

  A research team involving UCLH clinicians has found a way to reduce the side effects of treatment for a disorder of the adrenal glands.

• COVID-19 NHS vaccination centre to reopen at Islington Business Design Centre

  UCLH NHS Foundation Trust has once again formed a partnership with the Business Design Centre in Islington to reopen a large-scale COVID-19 vaccination centre on site from Saturday 18 December.

• New national study on long-term health impacts of COVID-19 launched

  UCLH will be part of a major UK research study looking at the long-term health impacts of COVID-19.

• Increase in delirium, rare brain inflammation and stroke linked to COVID-19

  Neurological complications of COVID-19 can include delirium, brain inflammation, stroke and nerve damage, finds a new UCL and UCLH-led study.

• History making decision announced for Thalassaemia patients!

  Outcome of National Institute for Health and Care Excellence (NICE) Technology Appraisal for Exagamglogene autotemcel (Exa-cel) for treating transfusion- dependent beta thalassaemia [ID4015] in individuals 12 years and over. 

• Cystic fibrosis drug tested to fight inflammation in COVID-19

  Patients with COVID-19 will be given the cystic fibrosis drug ‘Dornase alfa’ to determine if it can help improve survival by reducing excess inflammation in the lungs in a trial at UCLH.

• Lower Gastrointestinal suspected cancer pathway

  This page is for patients who have been referred on a suspected cancer pathway.

• Information for carers of children or young people having mIBG treatment

  This page has been written for parents, carers and family members who are acting as carers and comforters for children and young people having radioactive mIBG treatment.